These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24503357)

  • 1. Symptom predictability in gastroesophageal reflux disease and role of proton pump inhibitor test.
    Estores DS
    Gastroenterol Clin North Am; 2014 Mar; 43(1):27-38. PubMed ID: 24503357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.
    Pace F; Pace M
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):423-7. PubMed ID: 20678016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease.
    Bytzer P; Jones R; Vakil N; Junghard O; Lind T; Wernersson B; Dent J
    Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1360-6. PubMed ID: 22813439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proton pump inhibitor (PPI) test in GERD: does it still have a role?
    Gasiorowska A; Fass R
    J Clin Gastroenterol; 2008 Sep; 42(8):867-74. PubMed ID: 18645525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
    Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
    J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory based investigations for diagnosing gastroesophageal reflux disease.
    Dolder M; Tutuian R
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):787-98. PubMed ID: 21126694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proton pump inhibitor test for gastroesophageal reflux disease: optimal cut-off value and duration.
    de Leone A; Tonini M; Dominici P; Grossi E; Pace F;
    Dig Liver Dis; 2010 Nov; 42(11):785-90. PubMed ID: 20452300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Belching: dyspepsia or gastroesophageal reflux disease?
    Lin M; Triadafilopoulos G
    Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease.
    Kahrilas PJ; Howden CW; Hughes N
    Am J Gastroenterol; 2011 Aug; 106(8):1419-25; quiz 1426. PubMed ID: 21537361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of the PPI test for detection of GERD in Korean patients and factors associated with PPI responsiveness.
    Cho YK; Choi MG; Lim CH; Nam KW; Chang JH; Park JM; Lee IS; Kim SW; Choi KY; Chung IS
    Scand J Gastroenterol; 2010 May; 45(5):533-9. PubMed ID: 20180645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gastroesophageal reflux disease--diagnosis and management].
    Wojtuń S; Gil J; Jałocha Ł; Błaszak A; Wojtkowiak M
    Pol Merkur Lekarski; 2009 May; 26(155):512-6. PubMed ID: 19606713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structured diagnostic and treatment approach versus the usual primary care approach in patients with gastroesophageal reflux disease: a cluster-randomized multicenter study.
    Bergquist H; Agréus L; Tillander L; Johnsson F; Sörngård H; Sjöstedt S; Hellström PM
    J Clin Gastroenterol; 2013 Aug; 47(7):e65-73. PubMed ID: 23426452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the GerdQ questionnaire for the diagnosis of gastro-oesophageal reflux disease.
    Jonasson C; Wernersson B; Hoff DA; Hatlebakk JG
    Aliment Pharmacol Ther; 2013 Mar; 37(5):564-72. PubMed ID: 23289763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Questionnaires for the diagnosis of gastroesophageal reflux disease: are they really useful?
    Ciriza de Los Ríos C
    Rev Esp Enferm Dig; 2016 Apr; 108(4):171-3. PubMed ID: 26938193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical symptoms of FSSG in gastroesophageal reflux disease are critical for PPI treatment: Japanese multi-centers with 185 patients.
    Komatsu-Tanaka M; Iwakiri R; Fujimoto K; Fujiwara Y; Inamori M; Tanaka J; Shimatani T; Akiyama J; Ando T; Manabe N; Kinjo F; Deguchi R; Kusano M
    Dig Endosc; 2012 Nov; 24(6):407-11. PubMed ID: 23078431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients.
    Bytzer P; van Zanten SV; Mattsson H; Wernersson B
    Aliment Pharmacol Ther; 2012 Oct; 36(7):635-43. PubMed ID: 22860764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptoms and quality of life in underweight gastroesophageal reflux disease patients and therapeutic responses to proton pump inhibitors.
    Hongo M; Miwa H; Kusano M;
    J Gastroenterol Hepatol; 2012 May; 27(5):913-8. PubMed ID: 22142515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pragmatic symptom-based approach.
    Kuo P; Holloway RH
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):765-73. PubMed ID: 21126692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution of proton pump inhibitors for the treatment of gastroesophageal reflux disease.
    Friedlander EA; Pallentino J; Miller SK; VanBeuge SS
    J Am Acad Nurse Pract; 2010 Dec; 22(12):674-83. PubMed ID: 21129076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.